KATHLEEN STEWART: Open Payments
NPI 1114110947 · CHEHALIS, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,828 in 99 payments from 13 companies in 2025. Trend: 2023 $1,578 · 2024 $1,977 · 2025 $1,828
Food & beverage: $1,729Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 36 | $645 |
| ABBVIE INC. | 23 | $398 |
| Organon LLC | 10 | $151 |
| UCB, Inc. | 7 | $136 |
| Amgen Inc. | 6 | $119 |
| Lilly USA, LLC | 4 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| GENZYME CORPORATION | 3 | $56 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $32 |
Products named: TREMFYA, SKYRIZI, Bimzelx, OTEZLA, DUPIXENT, TALTZ, RINVOQ, LIBTAYO.
Industry payments across WA — which companies pay providers there.
